Therefore, the global cardiac arrhythmias
therapeutics market presents an urgent need for the development of biological drugs, which can target the gene and thus, improve cardiac functioning.
There are a lot of factors that can cause cardiac arrhythmia
in trauma patients, such as abnormal tissue perfusion, vagosympathetic stimulus, electrical gradient difference between normal and injured tissue, aberrant conductions occurred after myocardial damage, electrolyte imbalance, catecholamine discharge, pain, and anxiety.
Male soldiers between 18 to 40 years of age; with no known coronary artery disease and presenting with cardiac arrhythmias
, not secondary to electrolytes imbalances, hormonal disorders or drugs intake were included in the study through consecutive sampling from hospital record papers.
A person who is suffering from cardiac arrhythmia
for a long time is at increasing risk of cardiac arrest as the electric system of the person is not functioning properly.
Prevalence of cardiac arrhythmias
in dogs referred to Shiraz University Veterinary Teaching Hospital.
Detecting and treating cardiac arrhythmias
is an important therapeutic goal in cardiology.
The EnSite Precision Cardiac Mapping System gives a three-dimensional view of a patient's heart, helping surgeons identify the site and origin of cardiac arrhythmias
and abnormal heart rhythms, and treat the condition with a high success rate.
Radiofrequency ablation of cardiac arrhythmias
uses low voltage and high frequency electrical energy.
From 2010 through 2015, five reviews and six research studies were published that continued to look at modifiable risk factors for cardiac arrhythmias
and sudden cardiac arrest in patients undergoing hemodialysis.
Air pollution and the triggering of cardiac arrhythmias
. Curr Opin Cardiol 25(1):16-22; doi:10.1097/HC0.0b013e32833358cd.
"This is a technology that is going to help us reach more patients at risk for cardiac arrhythmias
and help healthcare systems more efficiently manage difficult patient populations," said Randy Lieberman, M.D., director of electrophysiology at Detroit Medical Center.
Topera, Inc., a venture-backed medical device company, has developed a novel 3D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias